Integra LifeSciences Holdings Corporation
IART
$9.55
-$0.02-0.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 68.47% | 98.88% | -1,813.86% | -230.14% | 281.70% |
| Total Depreciation and Amortization | -0.24% | 2.20% | 1.36% | -16.78% | 24.27% |
| Total Amortization of Deferred Charges | -22.81% | -30.42% | 36.46% | -1.07% | 4.87% |
| Total Other Non-Cash Items | 40.66% | -103.78% | 402,841.88% | 104.18% | 62.75% |
| Change in Net Operating Assets | -163.17% | 234.75% | 26.86% | -105.67% | -453.29% |
| Cash from Operations | -71.11% | 358.64% | 179.23% | -122.19% | 125.66% |
| Capital Expenditure | -13.58% | 24.77% | 30.34% | 2.30% | 0.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3,995.60% | 71.24% | 78.54% | -133.07% | 9.96% |
| Cash from Investing | -123.94% | 27.99% | 39.73% | -745.38% | 59.13% |
| Total Debt Issued | -91.77% | 4,579.84% | -76.29% | 53.67% | 62.39% |
| Total Debt Repaid | 95.91% | -3,762.72% | -4.22% | 61.84% | 3.85% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | 31.16% | 55.38% | 79.12% | 18.07% | -1,424.56% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -78.67% | 99.58% | -581.00% | -- | -- |
| Cash from Financing | 337.60% | 51.54% | -159.75% | 594.78% | 64.10% |
| Foreign Exchange rate Adjustments | 301.12% | -106.32% | 179.93% | 155.76% | -204.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.95% | 167.35% | -191.43% | -123.29% | 39,616.46% |